Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Real-time Estimate Cboe BZX
Other stock markets
 02:00:18 2024-04-19 pm EDT 		5-day change 1st Jan Change
893.6 USD -0.04% Intraday chart for Regeneron Pharmaceuticals, Inc. -1.15% +1.83%
Apr. 17 UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating MT
Apr. 17 The market is pinning its hopes on earnings reports Our Logo

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. REGN Stock
  4. Revisions Regeneron Pharmaceuticals, Inc.